Authors’ Reply to Vrachatis et al. “Pharmaco-Immunomodulatory Therapy in COVID-19”-Reference-Cited by-同舟云学术

Authors’ Reply to Vrachatis et al. “Pharmaco-Immunomodulatory Therapy in COVID-19”

Published:2020-09 Issue:14 Volume:80 Page:1501-1503
ISSN:0012-6667
Container-title:Drugs
language:en
Short-container-title:Drugs

Author:

Rizk John G.^ORCID,Kalantar-Zadeh Kamyar,Mehra Mandeep R.,Lavie Carl J.,Rizk Youssef,Forthal Donald N.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical)

Link

https://link.springer.com/content/pdf/10.1007/s40265-020-01396-8.pdf

Reference15 articles.

1. Vrachatis DA, Giotaki SG, Giannopoulos G, Deftereos S, Reimers B. Comment on “Pharmaco-Immunomodulatory Therapy in COVID-19”. Drugs. 2020. [Note to Production: Please insert the DOI number after generation]

2. Rizk JG, Kalantar-Zadeh K, Mehra MR, Lavie CJ, Rizk Y, Forthal DN. Pharmaco-immunomodulatory therapy in COVID-19 [published online ahead of print, 2020 Jul 21]. Drugs. 2020. https://doi.org/10.1007/s40265-020-01367-z.

3. Deftereos SG, Giannopoulos G, Vrachatis DA, et al. Effect of colchicine vs standard care on cardiac and inflammatory biomarkers and clinical outcomes in patients hospitalized with coronavirus disease 2019: the GRECCO-19 randomized clinical trial. JAMA Netw Open. 2020;3(6):e2013136. https://doi.org/10.1001/jamanetworkopen.2020.13136(published 2020 Jun 1).

4. Slobodnick A, Shah B, Krasnokutsky S, Pillinger MH. Update on colchicine, 2017. Rheumatology (Oxford). 2018;57(suppl_1):i4–i11. https://doi.org/10.1093/rheumatology/kex453.

5. Colcrys [package insert]. Philadelphia, PA: AR Scientific, Inc.; 2009. https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/022353lbl.pdf. Accessed 15 Aug 2020.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hexahydrocurcumin from Zingiberis rhizoma attenuates lipopolysaccharide-induced acute pneumonia through JAK1/STAT3 signaling pathway;Phytomedicine;2024-01

2. To Anticoagulate or Not to Anticoagulate in COVID-19: Lessons after 2 Years;Seminars in Thrombosis and Hemostasis;2022-04-25

3. Low-dose aspirin for early COVID-19: does the early bird catch the worm?;Expert Opinion on Investigational Drugs;2021-07-12

4. Sucking Bruises in Infancy;Mayo Clinic Proceedings;2021-05

5. In Reply–Use of Famotidine and Risk of Severe Course of Illness in Patients With COVID-19;Mayo Clinic Proceedings;2021-05